Keywords: profits, climb, belgium, ucb, belgian, pharmaceutical, chemical
Profits climb 30% at Belgium's UCB
Article | 09 February 1999
UCB, the Belgian pharmaceutical, chemical and film group, has posted1998 pretax profits of 9.75 billion Belgian francs ($273.7 million), a rise of 6%, ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- US Supreme Court says patent settlement can "sometimes" be illegal
- InSite Vision joins Merck & Co and Pfizer in patent infringement law suit against
- Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
- Additional indications in Japan for Roche's Avastin and Astellas' Prograf
- Highlights of EHA meeting: Novartis' Jakavi; Bristol-Myers and AbbVie's elotuzumab; Janssen's ibrutinib
